Search

everythinglearnresearchcommunity

for

Search:↓

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Low serum ferritin levels are linked to hair loss in women.

Hair loss improved with treatment and successful transplant.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Low iron levels may be linked to some types of hair loss in women.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Metformin can cause hair loss in some women with PCOS.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Low iron levels are linked to more hair loss in non-menopausal women.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Iron deficiency is not a significant cause of hair loss in women.

Most women with excessive hair growth have a hormonal cause.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.